Journal updates

If your manuscript has been declined, and you are planning to submit your article to another of the four AAPS journals (AAPS Open, The AAPS Journal, AAPSPharmSciTech, or Pharmaceutical Research), we can help make the peer review process faster and smoother by extending the use of previous peer reviewer comments! Portable Peer Review, an opt-into service available for any author of these journals, allows us to share, between the portfolio, previous peer review comments and reviewer names, subject to approval of all parties. This can help speed up the assessment process, should the editor choose to make a decision on the basis of the comments and revision. Interested?  Email us (this opens in a new tab) with the name of the journal to which you are going to submit. Note: Portable peer review is opt-in only, available at the authors’ preference, and the reviewer identities and comments will only be shared between offices, not to the author.

In recent years, there has been significant advancement in academic understanding of the underpinning science governing process and product performance as well as in the industry where sophisticated tools and techniques have been employed to develop and fast-track robust manufacturing processes. The AAPS PharmSciTech special issue entitled ‘Modeling and Simulations of Drug Product Manufacturing Unit Operations (this opens in a new tab)’ features contributions in modeling and simulations of drug product manufacturing unit operations, and regulatory opinions from invited global experts.

The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation (this opens in a new tab)

 In this review, the authors describe the COVID-19 vaccines that are currently tested in clinical trials and provided in-depth insight into the various types of vaccines, their compositions, advantages, and potential limitations. They also address how challenges in vaccine distribution and administration may be alleviated by applying vaccine-stabilization strategies and the use of specific mucosal immune response-inducing, non-invasive routes of administration, which must be considered early in the development process.

Advancements in Modified-release Oral Drug Delivery: Delivery throughout the Gastrointestinal Tract

Inhaled Drug Delivery of Biologics for Therapeutic and Vaccination

Delivery of Proteins and Peptides: What Is on the Forefront Based on Our Experience from the COVID-19 Pandemic?

Advancements in Amorphous Solid Dispersions to Improve Bioavailability

Novel Advances in 3-D Printing Technology in Drug Delivery

Submit Today! (this opens in a new tab)

AAPS Open is proud to announce new Editor-in-Chief Dr. Andrea Allmendinger. Dr. Allmendinger obtained her PhD in Pharmaceutical Technology from the University of Basel and joined the Pharmaceutical Development department of Roche/Genentech in Basel in 2013, where she is responsible for formulation and process development for clinical Phase I-III projects and commercial transfer activities for both large molecules and for synthetic drugs.

AAPS PharmSciTech High Impact Article Award Recognizing an article published in the last two years in AAPS PharmSciTech that is judged exceptional by the editors for its impact on pharmaceutical technology.

Awardee/Corresponding Author: Peter Mack, Ph.D., Astrazeneca Co-Authors: Amber Doty, Jon Schroeder, Kou Vang, Mark Sommerville, Ph.D., Mervin Taylor, Brad Flynn, and David Lechuga-Ballesteros, Ph.D.

Watch the video here. (this opens in a new tab)